已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Repeat corneal transplantation in Southern China: Indications, surgical technique, outcomes, and risk factors for repeat keratoplasty failure

医学 外科 角膜移植 移植 眼科
作者
Qi Zheng,Qinxiang Zheng,Wuhe Chen,Jinyang Li,Zelin Zhao,Haiou Wang,Dan Jiang,Wei Chen
出处
期刊:Indian Journal of Ophthalmology [Medknow]
卷期号:72 (Suppl 3): S482-S487
标识
DOI:10.4103/ijo.ijo_3333_23
摘要

Purpose: To report the indications, surgical techniques, and outcomes of repeat keratoplasty and evaluate the risk factors for graft failure in the Chinese population. Methods: The medical records of 216 patients (243 cases) who underwent at least two keratoplasties at a leading eye hospital in southern China between 2011 and 2020 were retrospectively reviewed. Indications and surgical procedures for repeat corneal transplantation were analyzed. Kaplan–Meier survival analysis was used to determine the graft survival rate after repeat keratoplasty. A multivariable survival model was used to assess the risk factors. Results: Repeated keratoplasties increased continuously from 2011 to 2020 ( P = 0.002). The most common primary indication was infectious keratitis (38.7%), and the most common reason for repeat keratoplasty was graft rejection (30.04%). Regraft techniques included penetrating keratoplasty (PK) in 165 cases (67.9%), deep lamellar keratoplasty (DALK) in 52 cases (21.40%), and endothelial keratoplasty (EK) in 26 cases (10.7%). Median survival was 5.3, 6.8, and 6.4 years for PK, DALK, and EK, respectively. The 5-year survival rate was 53.5%, 66.6%, and 69.8% for PK, DALK, and EK, respectively. The median LogMAR visual acuity was 1.4 for PK, 0.75 for DALK, and 1.2 for EK at the end of the follow-up. Multivariate analysis revealed that graft rejection is a risk factor for repeat keratoplasty failure ( P = 0.002). Conclusions: DALK and EK may provide better outcomes than PK in treating graft failure. Preventing and treating postoperative graft rejection may be key to improving regraft survival. These findings will aid in the management of failed corneal grafts.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ChastEA5完成签到 ,获得积分10
1秒前
危机的夏兰完成签到,获得积分10
1秒前
2秒前
鹿呦完成签到 ,获得积分10
5秒前
爱吃秋香鸡的向日葵完成签到,获得积分10
10秒前
小胖Cuber完成签到,获得积分10
11秒前
6wdhw完成签到 ,获得积分10
14秒前
17秒前
小鱼发布了新的文献求助10
20秒前
21秒前
领导范儿应助划水的洋采纳,获得30
21秒前
123完成签到,获得积分20
24秒前
和谐青文完成签到 ,获得积分10
26秒前
陈欣瑶完成签到 ,获得积分10
27秒前
follow发布了新的文献求助10
27秒前
橘子海完成签到 ,获得积分10
29秒前
冰西瓜完成签到 ,获得积分0
30秒前
CYJ完成签到 ,获得积分10
34秒前
34秒前
Yyyang发布了新的文献求助10
41秒前
机灵中蓝发布了新的文献求助30
42秒前
乐乐乐乐乐乐完成签到 ,获得积分10
42秒前
43秒前
一只不受管束的小狸Miao完成签到 ,获得积分10
44秒前
无极微光应助高谷菱采纳,获得20
47秒前
单纯的石头完成签到 ,获得积分10
47秒前
NCC发布了新的文献求助10
50秒前
清爽的人龙完成签到 ,获得积分10
52秒前
Orange应助科研通管家采纳,获得10
52秒前
852应助科研通管家采纳,获得10
52秒前
丘比特应助科研通管家采纳,获得10
52秒前
科研通AI2S应助科研通管家采纳,获得10
52秒前
52秒前
pikachu完成签到,获得积分10
53秒前
深情安青应助小李子采纳,获得50
54秒前
Sandy完成签到 ,获得积分10
59秒前
Moo完成签到 ,获得积分10
1分钟前
1分钟前
VVZD发布了新的文献求助10
1分钟前
科研通AI6.4应助NCC采纳,获得30
1分钟前
高分求助中
卤化钙钛矿人工突触的研究 2000
Malcolm Fraser : a biography 700
Signals, Systems, and Signal Processing 610
Software that combines deep learning,3D reconstruction and CFD to analyze the state of carotid arteries from ultrasound imaging 500
Bounds for Statistical Estimation in Semiparametric Models 500
Forced degradation and stability indicating LC method for Letrozole: A stress testing guide 500
Ideology and Meaning-Making under the Putin Regime 450
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6495184
求助须知:如何正确求助?哪些是违规求助? 8292076
关于积分的说明 17694462
捐赠科研通 5588647
什么是DOI,文献DOI怎么找? 2916457
邀请新用户注册赠送积分活动 1893336
关于科研通互助平台的介绍 1752396